JIE DUAN, AIDONG GU^*, WEI CHEN, CHANGHAO CHEN, FANGNAN SONG, FAXI CHEN, FANGFANG JIANG, HUIWEN XING

BIOCELL, Vol.47, No.12, pp. 2609-2615, 2023, DOI:10.32604/biocell.2023.042472 - 27 December 2023

Abstract Objective: This study aims to analyze the clinical significance and mechanism of nuclear factor erythroid 2-related factor 2 (NRF2) and glutathione peroxidase 4 (GPX4) in primary hepatic carcinoma (PHC). Methods: The expression of NRF2 and GPX4 in peripheral blood of patients with PHC was determined to analyze the diagnostic value of the two combined for PHC. The prognostic significance of NRF2 and GPX4 was evaluated by 3-year follow-up. Human liver epithelial cells THLE-2 and human hepatocellular carcinoma cells HepG2 were purchased, and the expression of NRF2 and GPX4 in the cells was determined. NRF2 and GPX4… More > Graphic Abstract

G. Naveen Sundar¹, Stalin Selvaraj², D. Narmadha¹, K. Martin Sagayam³, A. Amir Anton Jone³, Ayman A. Aly⁴, Dac-Nhuong Le^5,6,*

CMES-Computer Modeling in Engineering & Sciences, Vol.133, No.1, pp. 31-46, 2022, DOI:10.32604/cmes.2022.019914 - 18 July 2022

Abstract Hepatocellular carcinoma (HCC) is one major cause of cancer-related mortality around the world. However, at advanced stages of HCC, systematic treatment options are currently limited. As a result, new pharmacological targets must be discovered regularly, and then tailored medicines against HCC must be developed. In this research, we used biomarkers of HCC to collect the protein interaction network related to HCC. Initially, DC (Degree Centrality) was employed to assess the importance of each protein. Then an improved Graph Coloring algorithm was used to rank the target proteins according to the interaction with the primary target More >